Geron and Exeter Life Sciences have created a joint venture--Start Licensing Inc.--to manage intellectual property rights revolving around animal reproductive technology, a field that includes animal cloning. "It makes sound business sense to join a patent estate for nuclear transfer that has been tested and is recognized as dominant with a leading operating company in the field," said David Greenwood, Geron's CEO.

The new company "combines the full breadth of intellectual property rights to nuclear transfer cloning technology, including that developed at the Roslin Institute for cloning Dolly the sheep, with in-house state-of-the-art breeding services and expertise in advanced reproductive technologies, particularly in cloning, to provide a one-stop licensing and operating company," the companies said.

- here's the release [1] for more
- read the report [2] in the San Jose Business Journal

Related Articles:
BioArts ready to clone dogs, for a price [2]
Cloning advance could lead to designer babies [3]
Dolly creator scraps cloning, takes new approach [4]
Geron reports breakthrough in stem cell research [5]